BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 19381013)

  • 1. VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats.
    Farkas L; Farkas D; Ask K; Möller A; Gauldie J; Margetts P; Inman M; Kolb M
    J Clin Invest; 2009 May; 119(5):1298-311. PubMed ID: 19381013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular-Parenchymal Cross-Talk Promotes Lung Fibrosis through BMPR2 Signaling.
    Yanagihara T; Tsubouchi K; Zhou Q; Chong M; Otsubo K; Isshiki T; Schupp JC; Sato S; Scallan C; Upagupta C; Revill S; Ayoub A; Chong SG; Dvorkin-Gheva A; Kaminski N; Tikkanen J; Keshavjee S; Paré G; Guignabert C; Ask K; Kolb MRJ
    Am J Respir Crit Care Med; 2023 Jun; 207(11):1498-1514. PubMed ID: 36917778
    [No Abstract]   [Full Text] [Related]  

  • 3. Endothelial progenitor cells may inhibit apoptosis of pulmonary microvascular endothelial cells: new insights into cell therapy for pulmonary arterial hypertension.
    Xia L; Fu GS; Yang JX; Zhang FR; Wang XX
    Cytotherapy; 2009; 11(4):492-502. PubMed ID: 19526390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FTY720 prevents progression of renal fibrosis by inhibiting renal microvasculature endothelial dysfunction in a rat model of chronic kidney disease.
    Ni H; Chen J; Pan M; Zhang M; Zhang J; Chen P; Liu B
    J Mol Histol; 2013 Dec; 44(6):693-703. PubMed ID: 23907620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pigment epithelium-derived factor in idiopathic pulmonary fibrosis: a role in aberrant angiogenesis.
    Cosgrove GP; Brown KK; Schiemann WP; Serls AE; Parr JE; Geraci MW; Schwarz MI; Cool CD; Worthen GS
    Am J Respir Crit Care Med; 2004 Aug; 170(3):242-51. PubMed ID: 15117744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pigment epithelium-derived factor/vascular endothelial growth factor ratio plays a crucial role in the spontaneous regression of infant hemangioma and in the therapeutic effect of propranolol.
    Zhu L; Xie J; Liu Z; Huang Z; Huang M; Yin H; Qi W; Yang Z; Zhou T; Gao G; Zhang J; Yang X
    Cancer Sci; 2018 Jun; 109(6):1981-1994. PubMed ID: 29664206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of BMPR2 in the protective effect of fluoxetine against monocrotaline-induced endothelial apoptosis in rats.
    Wang Y; Zhang XH; Wang HL
    Can J Physiol Pharmacol; 2011 May; 89(5):345-54. PubMed ID: 21619414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-β1 downregulates vascular endothelial growth factor-D expression in human lung fibroblasts via the Jun NH2-terminal kinase signaling pathway.
    Cui Y; Osorio JC; Risquez C; Wang H; Shi Y; Gochuico BR; Morse D; Rosas IO; El-Chemaly S
    Mol Med; 2014 Mar; 20(1):120-34. PubMed ID: 24515257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors.
    Farkas L; Gauldie J; Voelkel NF; Kolb M
    Am J Respir Cell Mol Biol; 2011 Jul; 45(1):1-15. PubMed ID: 21057104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma endothelin-1 and vascular endothelial growth factor levels and their relationship to hemodynamics in idiopathic pulmonary fibrosis.
    Ventetuolo CE; Kawut SM; Lederer DJ
    Respiration; 2012; 84(4):299-305. PubMed ID: 22869459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
    Zhang L; Li Y; Liang C; Yang W
    Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated lung vascular endothelial growth factor overexpression protects against hypoxic pulmonary hypertension in rats.
    Partovian C; Adnot S; Raffestin B; Louzier V; Levame M; Mavier IM; Lemarchand P; Eddahibi S
    Am J Respir Cell Mol Biol; 2000 Dec; 23(6):762-71. PubMed ID: 11104729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
    Zhang SX; Wang JJ; Gao G; Parke K; Ma JX
    J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
    Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
    Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macitentan reduces progression of TGF-β1-induced pulmonary fibrosis and pulmonary hypertension.
    Bellaye PS; Yanagihara T; Granton E; Sato S; Shimbori C; Upagupta C; Imani J; Hambly N; Ask K; Gauldie J; Iglarz M; Kolb M
    Eur Respir J; 2018 Aug; 52(2):. PubMed ID: 29976656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased deposition of chondroitin/dermatan sulfate glycosaminoglycan and upregulation of β1,3-glucuronosyltransferase I in pulmonary fibrosis.
    Venkatesan N; Ouzzine M; Kolb M; Netter P; Ludwig MS
    Am J Physiol Lung Cell Mol Physiol; 2011 Feb; 300(2):L191-203. PubMed ID: 21056957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The small heat-shock protein αB-crystallin is essential for the nuclear localization of Smad4: impact on pulmonary fibrosis.
    Bellaye PS; Wettstein G; Burgy O; Besnard V; Joannes A; Colas J; Causse S; Marchal-Somme J; Fabre A; Crestani B; Kolb M; Gauldie J; Camus P; Garrido C; Bonniaud P
    J Pathol; 2014 Mar; 232(4):458-72. PubMed ID: 24307592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interruption of vascular endothelial growth factor receptor 2 signaling induces a proliferative pulmonary vasculopathy and pulmonary hypertension.
    Winter MP; Sharma S; Altmann J; Seidl V; Panzenböck A; Alimohammadi A; Zelniker T; Redwan B; Nagel F; Santer D; Stieglbauer A; Podesser B; Sibilia M; Helbich T; Prager G; Ilhan-Mutlu A; Preusser M; Lang IM
    Basic Res Cardiol; 2020 Sep; 115(6):58. PubMed ID: 32880713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-11 system participates in pulmonary artery remodeling and hypertension in pulmonary fibrosis.
    Milara J; Roger I; Montero P; Artigues E; Escrivá J; Cortijo J
    Respir Res; 2022 Nov; 23(1):313. PubMed ID: 36376885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.